NZNew Zealand introduced nationwide roadside drug testing in July 2026, beginning in Wellington in December 2025. Over six months, 4,145 tests were conducted, with the majority in Wellington and Auckland. Of those tested, 136 returned positive results, yielding a 3.3% positivity rate. Testing focuses on cannabis, methamphetamine, and MDMA, with no assessment of actual impairment. The program uses a predetermined selection method to avoid biased targeting, though critics argue it lacks comprehensive evaluation of driver impairment. Health experts have criticized the initiative for not addressing impairment directly.
Bias read (Center): The article presents factual data about the implementation and outcomes of the roadside drug testing program without overtly endorsing or opposing the policy. While it mentions criticism from health experts, it does not frame the issue as a partisan debate or emphasize ideological positions. The phr
